Rockefeller Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Rockefeller Capital Management's AXSM Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Axsome Therapeutics (AXSM) stake by 2.8% in Q3 2026, selling an estimated $22.8K and leaving 3,654 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #1959.
Rockefeller Capital Management first reported a position in AXSM in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.36M in Q4 2025. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Rockefeller Capital Management held 3,654 shares of Axsome Therapeutics worth $674K as of Q3 2026.
- Rockefeller Capital Management sold 105 Axsome Therapeutics shares in Q3 2026, an estimated $22.8K.
- Axsome Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1959 holding.
- Rockefeller Capital Management first reported a position in Axsome Therapeutics in Q1 2020 and has held it in 17 quarters since.
- Rockefeller Capital Management's Axsome Therapeutics position peaked at $1.36M in Q4 2025.
- 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.